DR JAD WEIR & PARTNERS — All Prescriptions & Medications — Page 14
Practice Code: B81040 | HULL, HU9 5HH
Showing results 651-700 of 738
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tube feed 1 kcal/ml peptide based (0914041) | 15 | 602.0K | £19.6K | +68.8% ▲ |
| 15 | 2,500 | £520 | +49.3% ▲ | |
| 15 | 580 | £2.4K | +22.3% ▲ | |
| Labetalol hydrochloride | 14 | 1,864 | £185 | -38.3% ▼ |
| Clonidine hydrochloride | 14 | 733 | £406 | -23.4% ▼ |
| Rutosides | 14 | 1,568 | £345 | +8.1% ▲ |
| Reboxetine | 14 | 210 | £64 | -9.1% ▼ |
| Ethosuximide | 14 | 1,916 | £3.1K | -5.1% ▼ |
| Insulin detemir | 14 | 80 | £672 | -82.1% ▼ |
| Raloxifene hydrochloride | 14 | 224 | £35 | -5.2% ▼ |
| Cabergoline | 14 | 120 | £223 | -9.7% ▼ |
| Liquid additive lactase (0913121) | 14 | 133 | £152 | +231.1% ▲ |
| Diclofenac sodium | 14 | 1,880 | £281 | -72.4% ▼ |
| Piroxicam | 14 | 1,568 | £41 | -75.6% ▼ |
| Tafluprost | 14 | 420 | £171 | -24.5% ▼ |
| 14 | 73 | £55 | +34.7% ▲ | |
| Cimetidine | 13 | 780 | £70 | -30.3% ▼ |
| Nicardipine hydrochloride | 13 | 1,092 | £104 | +29.5% ▲ |
| Gemfibrozil | 13 | 364 | £221 | +28.7% ▲ |
| Simple | 13 | 2,650 | £24 | +13.3% ▲ |
| Lofepramine hydrochloride | 13 | 728 | £312 | -56.5% ▼ |
| Atomoxetine hydrochloride | 13 | 364 | £692 | -61.6% ▼ |
| Ertugliflozin | 13 | 350 | £349 | -27.9% ▼ |
| Solifenacin/tamsulosin | 13 | 390 | £341 | -36.7% ▼ |
| Other compound vitamin/mineral formulation preparations | 13 | 390 | £39 | -59.5% ▼ |
| Powder 5 kcal/g high energy, low protein formula (0913094) | 13 | 76.0K | £7.7K | +80.4% ▲ |
| RtS 3.3 kcal/ml energy and higher protein liquid (0913141) | 13 | 698 | £1.4K | +87.3% ▲ |
| Specialist food replacer flour type mixes (0913261) | 13 | 43.0K | £699 | +65.5% ▲ |
| Diethylamine salicylate | 13 | 1,200 | £37 | -51.8% ▼ |
| Betamethasone sodium phosphate | 13 | 210 | £46 | -49.8% ▼ |
| Brimonidine tart (Rosacea) | 13 | 390 | £416 | +151.8% ▲ |
| 13 | 220 | £318 | +18.7% ▲ | |
| 13 | 1,110 | £2.6K | +56.1% ▲ | |
| 13 | 2,402 | £96 | +0.8% vs avg | |
| 13 | 44 | £440 | +9.2% ▲ | |
| 13 | 520 | £304 | -32.7% ▼ | |
| 13 | 400 | £1.3K | +10.7% ▲ | |
| Sucralfate | 12 | 5,248 | £5.9K | +42.9% ▲ |
| Loperamide hydrochloride and simeticone | 12 | 1,320 | £553 | +134.7% ▲ |
| Naldemedine | 12 | 84 | £120 | +36.6% ▲ |
| Glyceryl trinitrate | 12 | 360 | £448 | -9.7% ▼ |
| Minoxidil | 12 | 336 | £86 | +7.7% ▲ |
| Omega-3-acid ethyl esters | 12 | 336 | £162 | -43.2% ▼ |
| Aclidinium bromide | 12 | 12 | £371 | -54.8% ▼ |
| Pimozide | 12 | 346 | £134 | +147.5% ▲ |
| Aspirin combined preparations | 12 | 724 | £65 | +133.8% ▲ |
| Valproic acid | 12 | 720 | £168 | -18.0% ▼ |
| Mebendazole | 12 | 184 | £15 | +4.8% ▲ |
| Insulin glulisine | 12 | 60 | £340 | -44.0% ▼ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 12 | 84.0K | £1.1K | +72.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.